Covance, Inc. (NYSE:CVD)

CAPS Rating: 4 out of 5

A drug development services company providing a range of early stage and late stage product development services on a worldwide basis primarily to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar RTChokies (95.89) Submitted: 1/16/2012 10:00:11 AM : Outperform Start Price: $44.22 CVD Score: +5.64

fair value is 65

Featured Broker Partners


Advertisement